Compare Natera Inc. Common Stock (NTRA) vs Verizon Communications Inc (VZ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Natera Inc. Common Stock vs Verizon Communications Inc — how do they compare? Natera Inc. Common Stock trades at $393.93 (market cap $57.03B), while Verizon Communications Inc trades at $44.83 (market cap $184.56B). The key difference: Verizon Communications Inc is far larger — about 3.2× Natera Inc. Common Stock's market cap, and Verizon Communications Inc pays a 6.37% dividend while Natera Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Natera Inc. Common Stock for 0 Days and Verizon Communications Inc for 109 Days on average.
| NTRA | VZ | |
|---|---|---|
Market Cap | $57.03B | $184.56B |
Volume | 1,131,157 | 28,067,100 |
Sector | Health | Media |
52-Week High | $425.64 | $51.45 |
52-Week Low | $179.42 | $38.40 |
Typical Hold Time | 0 Days | 109 Days |
Enterprise Value | $56.18B | $371.26B |
Dividend Yield | — | 6.37% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
NTRA trades at $395.66, down 0.53% today but remains near recent highs. The stock shows mixed technical signals with neutral momentum indicators. Fundamentally, the company demonstrates strong revenue growth ($2.31B in 2025, projected $2.7B in 2026) but continues to operate at a net loss (-$208M in 2025). Recent positive developments include FDA Breakthrough Device designation for its multi-cancer detection assay and regulatory approval in Japan for Signatera.
NTRA presents a growth story with significant analyst support (89% buy ratings) but carries execution risks. The stock trades at premium valuations (P/S 20.48) while still unprofitable. Key catalysts include clinical trial progress and international expansion, though investors face risks from ongoing losses and competitive pressures in precision medicine.
Verizon (VZ) trades at $43.53, up 1.75% today, with a bearish technical signal despite recent earnings beats. The stock shows attractive valuation metrics including a P/E of 11.34 and dividend yield support, while maintaining strong cash flow generation of $37.14B from operations in 2025. Recent developments include a joint satellite venture with AT&T and T-Mobile announced October 1, 2026, and upcoming Q3 earnings on October 26, 2026.
VZ presents a value opportunity with solid fundamentals but faces technical headwinds. The company's consistent dividend payments and improving cash flow trends provide income stability, while competitive pressures in the telecom sector and high debt levels ($144B total debt) represent ongoing challenges. Analyst consensus targets $47.83 with 38% buy ratings, suggesting moderate upside potential from current levels.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Natera Inc. Common Stock
Natera, Inc. develops and provides cell-free DNA-based genetic testing across women's health, oncology, organ health, and rare disease, with flagship products including Panorama for noninvasive prenatal screening and Signatera for cancer recurrence monitoring.
Read more on NTRA →About Verizon Communications Inc
Verizon Communications Inc. is an integrated telecommunications company that provides wire line voice and data services, wireless services, Internet services, and published directory information. The Company also provides network services for the federal government including business phone lines, data services, telecommunications equipment, and payphones.
Read more on VZ →
